Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related
Sarepta Says FDA Postpones Advisory Committee Meeting to Review Eteplirsen Due to Severe Weather Storm in the Washington D.C.
Related ACAD
These were The Top 10 Trending Stocks This Week
Biotechs Are Ripping Following IPAB Ruling
The Stock Market Is Not Ready To Give Up (Seeking Alpha)

Analysts at Deutsche Bank initiated coverage on shares of Sarepta Therapeutics (NASDAQ: SRPT) with a “buy” rating. The target price range for Sarepta Therapeutics is set to $45. Sarepta Therapeutics' shares closed at $33.03 yesterday.

Jefferies initiated coverage on shares of ACADIA Pharmaceuticals (NASDAQ: ACAD) with a “buy” rating. The target price for ACADIA Pharmaceuticals is set to $13. ACADIA Pharmaceuticals' stock closed at $6.18 yesterday.

Topeka Capital initiated coverage on shares of Schnitzer Steel Industries (NASDAQ: SCHN) with a “hold” rating. The target price for Schnitzer Steel Industries is set to $27. Schnitzer Steel Industries' shares closed at $28.60 yesterday.

Analysts at Bank of America initiated coverage on shares of Pluristem Therapeutics (NASDAQ: PSTI) with a “hold” rating. The target price for Pluristem Therapeutics is set to $3.50. Pluristem Therapeutics' shares closed at $3.17 yesterday.

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (ACAD + PSTI)

View Comments and Join the Discussion!